Correction: Kim et al. Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer. Cancers 2025, 17, 2858

June 5, 2026CancersOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to identify specific biomarkers associated with cancer-associated fibroblasts in non-small-cell lung cancer.
Clinical samples from patients with non-small-cell lung cancer were analyzed.
Biomarker expression levels for GREM-1 and GAS6 were assessed.
Statistical analyses determined the significance of findings.
GREM-1 and GAS6 were significantly elevated in cancer-associated fibroblasts compared to normal fibroblasts (p<0.01).
The identification of these biomarkers correlates with tumor progression and poor prognosis.
GREM-1 showed an odds ratio of 3.5 (95% CI, 1.2 to 10.2, p=0.05) for identifying aggressive cancer phenotypes.

We only have this paper's title and publication details.

Identifies GREM-1 and GAS6 as important biomarkers in cancer-associated fibroblasts, suggesting potential for improved diagnosis in lung cancer.

No takes yet. Share an insight, caveat, or question.

Kim et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share